Trial
NCT00395603
Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Organon and Co
Collaborators
—
Condition
Cardiovascular Diseases
Intervention
MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 6 Weeks
Why stopped
This study was terminated early due to poor recruitment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-15